A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF UPADACITINIB VERSUS TOFACITINIB IN CSDMARD-IR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA)

被引:1
作者
Edwards, Christopher [1 ]
Sawant, Ruta [2 ]
Du, Ella [3 ]
Cammarota, Jordan [3 ]
Tang, Patrick [3 ]
Garg, Vishvas [2 ]
Friedman, Alan [2 ]
Betts, Keith [3 ]
机构
[1] Univ Southampton, Southampton, Hants, England
[2] AbbVie Inc, N Chicago, IL USA
[3] Anal Grp Inc, Los Angeles, CA USA
关键词
ADALIMUMAB;
D O I
10.1136/annrheumdis-2019-eular.7189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0168
引用
收藏
页码:358 / 358
页数:1
相关论文
共 2 条
[1]   Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial [J].
Fleischmann, Roy ;
Mysler, Eduardo ;
Hall, Stephen ;
Kivitz, Alan J. ;
Moots, Robert J. ;
Luo, Zhen ;
DeMasi, Ryan ;
Soma, Koshika ;
Zhang, Richard ;
Takiya, Liza ;
Tatulych, Svitlana ;
Mojcik, Christopher ;
Krishnaswami, Sriram ;
Menon, Sujatha ;
Smolen, Josef S. .
LANCET, 2017, 390 (10093) :457-468
[2]   Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis [J].
van Vollenhoven, Ronald F. ;
Fleischmann, Roy ;
Cohen, Stanley ;
Lee, Eun Bong ;
Garcia Meijide, Juan A. ;
Wagner, Sylke ;
Forejtova, Sarka ;
Zwillich, Samuel H. ;
Gruben, David ;
Koncz, Tamas ;
Wallenstein, Gene V. ;
Krishnaswami, Sriram ;
Bradley, John D. ;
Wilkinson, Bethanie .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (06) :508-519